🇺🇸·May 20Research
Is It Time to Move Beyond Graft-Versus-Host Disease-Free, Relapse-Free Survival as a Primary End Point in Clinical Trials for Hematopoietic Cell Transplantation?
Publisher
A
ASCO JCO Journal
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ASCO JCO Journal
- Region
- USA
- Scope
- Research
- Published
- May 20, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ascopubs.org
Leave the platform to read the original full article on the publisher site.
Source: ASCO JCO Journal
Scope: Research
Related coverage
More related coverage
Hospital Clínic de Barcelona·23h ago
Clínic Barcelona marks 50 years since the first allogeneic bone marrow transplant
Hospital Clínic de Barcelona·23h ago
A clinical trial in patients with palindromic rheumatism shows that an immunomodulatory drug can prevent the development of rheumatoid arthritis
Universitätsklinikum Heidelberg·23h ago
Komplikationen nach Lebertransplantation und ökologische Nischen für Leukämiezellen: Medizinische Fakultät Heidelberg zeichnet hervorragende Nachwuchswissenschaftlerinnen aus
UNMC·1d ago